PERTANIKA JOURNAL OF SCIENCE AND TECHNOLOGY

J

• Anhê, F. F., Varin, T. V., Le Barz, M., Desjardins, Y., Levy, E., Roy, D., & Marette, A. (2015). Gut microbiota dysbiosis in obesity-linked metabolic diseases and prebiotic potential of polyphenol-rich extracts. Current Obesity Reports, 4(4), 389–400. https://doi.org/10.1007/s13679-015-0172-9

• Asemi, Z., Khorrami-Rad, A., Alizadeh, S. A., Shakeri, H., & Esmaillzadeh, A. (2014). Effects of synbiotic food consumption on metabolic status of diabetic patients: A double-blind randomized cross-over controlled clinical trial. Clinical Nutrition, 33(2), 198-203. https://doi.org/10.1016/j.clnu.2013.05.015

• Bakhshimoghaddam, F., Shateri, K., Sina, M., Hashemian, M. S., & Alizadeh, M. (2018). Daily consumption of synbiotic yogurt decreases liver steatosis in patients with non-alcoholic fatty liver disease: A randomized controlled clinical trial. The Journal of Nutrition, 148 (8), 1276-1284. https://doi.org/10.1093/jn/nxy088

• Boulangé, C. L., Neves, A. L., Chilloux, J., Nicholson, J. K., & Dumas, M. (2016). Impact of the gut microbiota on inflammation, obesity, and metabolic disease. Genome Medicine, 8(1), 42. https://doi.org/10.1186/s13073-016-0303-2

• Çakır, M., Aksel İşbilen, A., Eyüpoğlu, İ., Sağ, E., Örem, A., Mazlum Şen, T., Kaklıkkaya, N., & Kaya, G. (2017). Effects of long-term synbiotic supplementation in addition to lifestyle changes in children with obesity-related non-alcoholic fatty liver disease. Turkish Journal of Gastroenterology, 28(5), 377–383. https://doi.org/10.5152/tjg.2017.17084

• Capitán-Cañadas, F., Ortega-González, M., Guadix, E., Zarzuelo, A., Suárez, M. D., de Medina, F. S., & Martínez-Augustin, O. (2014). Prebiotic oligosaccharides directly modulate proinflammatory cytokine production in monocytes via activation of TLR4. Molecular Nutrition Food Research, 58(5), 1098-1110. https://doi.org/10.1002/mnfr.201300497

• Chan, C. K. Y., Tao, J., Chan, O. S., Li, H. B., & Pang, H. (2020). Preventing respiratory tract infections by synbiotic interventions: A systematic review and meta-analysis of randomized controlled trials. Advances in Nutrition, 11(4), 979-988. https://doi.org/10.1093/advances/nmaa003

• Chillarón, J. J., Roux, J. A. F., Benaiges, D., & Pedro-Botet, J. (2014). Subclinical cardiovascular disease in type 2 diabetes mellitus: To screen or not to screen. World Journal of Clinical Cases, 2(9), 415–421. https://doi.org/10.12998/wjcc.v2.i9.415

• Covasa, M., Stephens, R. W., Toderean, R., & Cobuz, C. (2019). Intestinal Sensing by gut microbiota: Targeting gut peptides. Frontiers in Endocrinology, 10, 82. https://doi.org/10.3389/fendo.2019.00082

• Dehghani, H., Heidari, F., Mozaffari-Khosravi, H., Nouri-Majelan, N., & Dehghani, A. (2016). Synbiotic supplementations for azotemia in patients with chronic kidney disease: a randomized controlled trial. Iranian Journal of Kidney Diseases, 10(6), 351-357.

• DiRienz, D. B. (2014). Effect of probiotics on biomarkers of cardiovascular disease: Implications for heart-healthy diets. Nutrition Reviews, 72(1), 18–29. https://doi.org/10.1111/nure.12084

• dos Santos, A. C., Ribeiro, D. A., da Cruz Ferreira, J. A., Aguiar, O., Waitzberg, D. L., & Alves, C. C. (2019). Inflammatory gene expression analysis after prebiotic, probiotic and synbiotic supplementation in experimental non-alcoholic fatty liver disease. Nutrition and Food Science, 49(1), 75-84. https://doi.org/10.1108/NFS-04-2018-0119

• Eslamparast, T., Poustchi, H., Zamani, F., Sharafkhah, M., Malekzadeh, R., & Hekmatdoost, A. (2014a). Synbiotic supplementation in non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled pilot study. The American Journal of Clinical Nutrition, 99(3), 535-42. https://doi.org/10.3945/ajcn.113.068890

• Eslamparast, T., Zamani, F., Hekmatdoost, A., Sharafkhah, M., Eghtesad, S., Malekzadeh, R., & Poustchi, H. (2014b). Effects of synbiotic supplementation on insulin resistance in subjects with the metabolic syndrome: A randomised, double-blind, placebo-controlled pilot study. British Journal of Nutrition, 112(3), 438–445. https://doi.org/10.1017/S0007114514000919

• Farrag, A., Bakhoum, S., Salem, M. A., El-Faramawy, A., & Gergis, E. (2013). The association between extracoronary calcification and coronary artery disease in patients with type 2 diabetes mellitus. Heart Vessels, 28(1), 12–18. https://doi.org/10.1007/s00380-011-0205-6

• Farrokhian, A., Raygan, F., Soltani, A., Tajabadi-Ebrahimi, M., Esfahani, M. S., Karami, A. A., & Asemi, Z. (2019). The effects of synbiotic supplementation on carotid intima-media thickness, biomarkers of inflammation and oxidative stress in people with overweight, diabetes and coronary heart disease: A randomized, double-blind, placebo-controlled trial. Probiotics and Antimicrobial Proteins, 11(1), 133-142. https://doi.org/10.1007/s12602-017-9343-1

• Ferrarese, R., Ceresola, E., Preti, A., & Canducci, F. (2018). Probiotics, prebiotics and synbiotics for weight loss and metabolic syndrome in the microbiome era. European Review for Medical and Pharmacological Sciences, 22(21), 7588–7605. https://doi.org/10.26355/eurrev_201811_16301

• Frece, J., Kos, B., Svetec, I. K., Zgaga, Z., Beganović, J., Lebos, A., & Susković, J. (2009). Synbiotic effect of Lactobacillus helveticus M92 and prebiotics on the intestinal microflora and immune system of mice. Journal of Dairy Research, 76(1), 98-104. https://doi.org/10.1017/S0022029908003737

• Gaede, P., Vedel, P., Larsen, N., Jensen, G. V. H., Parving, H., & Pedersen, O. (2003). Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. The New England Journal of Medicine, 348(5), 383-393. https://doi.org/10.1056/NEJMoa021778

• Gurry, T. (2017). Synbiotic approaches to human health and well-being. Microbial Biotechnology, 10(5), 1070–1073. https://doi.org/10.1111/1751-7915.12789

• Han, J.-L., & Lin, H.-L. (2014). Intestinal microbiota and type 2 diabetes: From mechanism insights to therapeutic perspective. World Journal of Gastroenterology, 20(47), 17737–17745. https://doi.org/10.3748/wjg.v20.i47.17737

• Heiss, C. N., & Olofsson, L. E. (2018). Gut microbiota-dependent modulation of energy metabolism. Journal of Innate Immunity, 10(3), 163–171. https://doi.org/10.1159/000481519

• Hernandez-Rodas, M. C., Valenzuela, R., & Videla, L. A. (2015). Relevant aspects of nutritional and dietary interventions in non-alcoholic fatty liver disease. International Journal of Molecular Science, 16(10), 25168-25198. https://doi.org/10.3390/ijms161025168

• Hinai, E. A. A., Kullamethee, P., Rowland, I. R., Swann, J., Walton, G. E., & Commane, D. M. (2019). Modelling the role of microbial ρ-cresol in colorectal genotoxicity. Gut Microbes, 10(3), 398–411. https://doi.org/10.1080/19490976.2018.1534514

• Hong, H. R., Ha, C. D., Kong, J. Y., Lee, S. H., Song, M. G., & Kang, H. S. (2014). Roles of physical activity and cardiorespiratory fitness on sex difference in insulin resistance in late elementary years. Journal of Exercise Nutrition and Biochemistry, 18(4), 361–369. https://doi.org/10.5717/jenb.2014.18.4.361

• Ipar, N., Aydogdu, S. D., Yildirim, G. K., Inal, M., Gies, I., Vandenplas, Y., & Dinleyici, E.C. (2015). Effects of synbiotic on anthropometry, lipid profile and oxidative stress in obese children. Beneficial Microbes, 6(6), 775–781. https://doi.org/10.3920/BM2015.0011

• Katsiki, N., Mikhailidis, D. P., & Mantzoros, C. S. (2016). Non-alcoholic fatty liver disease and dyslipidemia: An update. Metabolism, 65(8), 1109-23. https://doi.org/10.1016/j.metabol.2016.05.003

• Kellow, N. J., Coughlan, M. T., Savige, G. S., & Reid, C. M. (2014). Effect of dietary prebiotic supplementation on advanced glycation, insulin resistance and inflammatory biomarkers in adults with pre-diabetes: A study protocol for a double-blind placebo-controlled randomised crossover clinical trial. BMC Endocrine Disorders, 14(1), 55. https://doi.org/10.1186/1472-6823-14-55

• Kocełak, P., Olszanecka-Glinianowicz, M., & Chudek, J. (2012). Fibroblast growth factor 23 – Structure, function and role in kidney diseases. Advances in Clinical and Experimental Medicine, 21(3), 391–401.

• Larsen, N., Vogensen, F. K., van den Berg, F. W., Nielsen, D. S., Andreasen, A. S., Pedersen, B. K., Al-Soud, W. A., Sørensen, S. J., Hansen, L. H., & Jakobsen, M. (2010). Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLOS One, 5(2), e9085. https://doi.org/10.1371/journal.pone.0009085

• Malaguarnera, M., Vacante, M., Antic, T., Giordano, M., Chisari, G., Acquaviva, R., Mastrojeni, S., Malaguarnera, G., Mistretta, A., Volti, G. L. & Galvan, F. (2012). Bifidobacterium longum with fructo-oligosaccharides in patients with non-alcoholic steatohepatitis. Digestive Diseases and Sciences, 57(2), 545–553. https://doi.org/10.1007/s10620-011-1887-4

• Markowiak, P. & Śliżewska, K. (2017). Effects of probiotics, prebiotics, and synbiotics on human health. Nutrients, 9(9), 1021. https://doi.org/10.3390/nu9091021

• Martinez, K. B., Leone, V., & Chang, E. B. (2017). Western diets, gut dysbiosis, and metabolic diseases: Are they linked?. Gut Microbes, 8(2), 130–142. https://doi.org/10.1080/19490976.2016.1270811

• Mehal, W. Z. (2013). The Gordian knot of dysbiosis, obesity and NAFLD. Nature Reviews Gastroenterology and Hepatology, 10(11), 637-644. https://doi.org/10.1038/nrgastro.2013.146

• Moroti, C., Magri, L. F. S., Costa, M. d. R., Cavallini, D. C. U., & Sivieri, K. (2012). Effect of the consumption of a new symbiotic shake on glycemia and cholesterol levels in elderly people with type 2 diabetes mellitus. Lipids in Health and Disease, 11(1), 29. https://doi.org/10.1186/1476-511X-11-29

• Nakabayashi, I., Nakamura, M., Kawakami, K., Ohta, T., Kato, I., Uchida, K., & Yoshida, M. (2011). Effects of synbiotic treatment on serum level of ρ-cresol in haemodialysis patients: A preliminary study. Nephrology Dialysis Transplantation, 26(3), 1094–1098. https://doi.org/10.1093/ndt/gfq624

• Niwa, T. (2011). Role of indoxyl sulfate in the progression of chronic kidney disease and cardiovascular disease: Experimental and clinical effects of oral sorbent AST-120. Therapeutic Apheresis and Dialysis, 15(2), 120–124. https://doi.org/10.1111/j.1744-9987.2010.00882.x

• Noakes, M., Keogh, J. B., Foster, P. R., & Clifton, P. M. (2005). Effect of an energy-restricted, high-protein, low-fat diet relative to a conventional high-carbohydrate, low-fat diet on weight loss, body composition, nutritional status, and markers of cardiovascular health in obese women. American Journal of Clinical Nutrition, 81(6), 1298-306. https://doi.org/10.1093/ajcn/81.6.1298

• Plaza-Diaz, J., Ruiz-Ojeda, F. J., Gil-Campos, M. & Gil, A. (2019). Mechanisms of action of probiotics. Advances in Nutrition, 10(1), S49–S66. https://doi.org/10.1093/advances/nmy063

• Quigley, E. M., & Monsour, H. P. (2015). The gut microbiota and non-alcoholic fatty liver disease. Seminars in Liver Disease, 35(3), 262-269. https://doi.org/10.1055/s-0035-1562946

• Rabiei, S., & Hekmatdoost, A. (2019). New therapeutic agents to treat obesity and its related disorders: Prebiotic, probiotic and synbiotic supplementation. International Journal of Food and Nutritional Science, 6(1), 43-53.

• Raso, G. M., Simeoli, R., Iacono, A., Santoro, A., Amero, P., Paciello, O., Russo, R., D’Agostino, G., Di Costanzo, M., Canani, R. B., Calignano, A., & Meli, R. (2014). Effects of a Lactobacillus paracasei B21060 based synbiotic on steatosis, insulin signaling and toll-like receptor expression in rats fed a high-fat diet. The Journal of Nutritional Biochemistry, 25(1), 81–90. https://doi.org/10.1016/j.jnutbio.2013.09.006

• Russell, W. R., Gratz, S. W., Duncan, S. H., Holtrop, G., Ince, J., Scobbie, L., Duncan, G., Johnstone, A. M., Lobley, G. E., Wallace, R. J., Duthie, G. G., & Flint, H. J. (2011). High-protein, reduced-carbohydrate weight-loss diets promote metabolite profiles likely to be detrimental to colonic health. The American Journal of Clinical Nutrition, 93(5), 1062–1072. https://doi.org/10.3945/ajcn.110.002188

• Sáez-Lara, M. J., Robles-Sanchez, C., Ruiz-Ojeda, F. J., Plaza-Diaz, J., & Gil, A. (2016). Effects of probiotics and synbiotics on obesity, insulin resistance syndrome, type 2 diabetes and non-alcoholic fatty liver disease: A review of human clinical trials. International Journal of Molecular Science, 17(6), 928. https://doi.org/10.3390/ijms17060928

• Sanchez, M., Darimont, C., Drapeau, V., Emady-Azar, S., Lepage, M., Rezzonico, E., Ngom-Bru, C., Berger, B., Philippe, L., Ammon-Zuffrey, C., Leone, P., Chevrier, G., St-Amand, E., Marette, A., Doré, J., & Tremblay, A. (2014). Effect of Lactobacillus rhamnosus CGMCC1.3724 supplementation on weight loss and maintenance in obese men and women. The British Journal of Nutrition, 111(8), 1507–1519. https://doi.org/10.1017/S0007114513003875

• Sergeev, I. N., Aljutaily, T., Walton, G., & Huarte, E. (2020). Effects of synbiotic supplement on human gut microbiota, body composition and weight loss in obesity. Nutrients, 12(1), 222. https://doi.org/10.3390/nu12010222

• Singh, K., Kallali, B., Kumar, A., & Thaker, V. (2011). Probiotics: A review. Asian Pacific Journal of Tropical Biomedicine, 1(2), S287-S290. https://doi.org/10.1016/S2221-1691(11)60174-3

• Taghizadeh, M., Hashemi, T., Shakeri, H., Abedi, F., Sabihi, S., Alizadeh, S., & Asemi, Z. (2014). Synbiotic food consumption reduces levels of triacylglycerols and VLDL, but not cholesterol, LDL, or HDL in plasma from pregnant women. Lipids, 49(2), 155–161. https://doi.org/10.1007/s11745-013-3867-2

• Tajabadi-Ebrahimi, M., Sharifi, N., Farrokhian, A., Raygan, F., Karamali, F., Razzaghi, R., Taheri, S., & Asemi, Z. (2017). A randomized controlled clinical trial investigating the effect of synbiotic administration on markers of insulin metabolism and lipid profiles in overweight type 2 diabetic patients with coronary heart disease. Experimental and Clinical Endocrinology and Diabetes, 125(1), 21–27. https://doi.org/10.1055/s-0042-105441

• Tajadadi-Ebrahimi, M., Bahmani, F., Shakeri, H., Hadaegh, H., Hijijafari, M., Abedi, F., & Asemi, Z. (2014). Effects of daily consumption of synbiotic bread on insulin metabolism and serum high-sensitivity C-reactive protein among diabetic patients: A double-blind, randomized, controlled clinical trial. Annals of Nutrition and Metabolism, 65(1), 34–41. https://doi.org/10.1159/000365153

• Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., Egholm, M., Henrissat, B., Heath, A. C., Knight, R., & Gordon, J. I. (2009). A core gut microbiome in obese and lean twins. Nature, 457(7228), 480–484. https://doi.org/10.1038/nature07540

• Vajro, P., Lenta, S., Socha, P., Dhawan, A., McKiernan, P., Baumann, U., Durmaz, O., Lacaille, F., McLin, V., & Nobili, V. (2012). Diagnosis of non-alcoholic fatty liver disease in children and adolescents: Position paper of the ESPGHAN hepatology committee. Journal of Pediatric Gastroenterology and Nutrition, 54(5), 700–713. https://doi.org/10.1097/MPG.0b013e318252a13f

• Vaziri, N. D. (2016). Effect of synbiotic therapy on gut–derived uremic toxins and the intestinal microbiome in patients with CKD. Clinical Journal of the American Society of Nephrology, 11(2), 199–201. https://doi.org/10.2215/CJN.13631215

• World Health Organization. (2018). Diseases of the respiratory system. https://www.who.int/classifications/icd/revision/en/

• Yang, T., Richards, E. M., Pepine, C. J. & Raizada, M. K. (2018). The gut microbiota and the brain-gut-kidney axis in hypertension and chronic kidney disease. Nature Reviews Nephrology, 14(7), 442–456. https://doi.org/10.1038/s41581-018-0018-2

• Yao, C. K., Muir, J. G., & Gibson, P. R. (2016). Review article: Insights into colonic protein fermentation, its modulation and potential health implications. Alimentary Pharmacology and Therapeutics, 43(2), 181–196. https://doi.org/10.1111/apt.13456

• Yoo, J. Y., & Kim, S. S. (2016). Probiotics and prebiotics: Present status and future perspectives on metabolic disorders. Nutrients, 8(3), 173. https://doi.org/10.3390/nu8030173

• Zarrati M., Salehi E., Nourijelyani K., Mofid V., Zadeh M. J. H., Najafi F., Ghaflati Z., Bidad K., Chamari M., Karimi M., & Shidfar F. (2014). Effects of probiotic yogurt on fat distribution and gene expression of proinflammatory factors in peripheral blood mononuclear cells in overweight and obese people with or without weight-loss diet. Journal of the American College of Nutrition, 33(6), 417–425. https://doi.org/10.1080/07315724.2013.874937